Overview
Infera Health provides an AI-native platform that keeps medtech quality and regulatory tasks in continuous compliance across the design, build, and shipping stages. It works by monitoring changes in a client’s workspace, keeping FDA-ready documentation updated and auditable, and integrating with Google Drive, Jira, Confluence, and GitHub so all data lives in one system of record; its AI agents analyze sources, extract requirements, generate system components, and identify risks. Unlike traditional tools that treat compliance as a final checkpoint, it embeds quality into ongoing development and covers standards like ISO 13485, IEC 62304, and ISO 14971, with templates for startups and centralized portfolio management for larger teams. The goal is to speed up the delivery of life-saving medical devices by making quality engineering and regulatory compliance routine and effortless.
Work here?Claim your company
Simplify's Take
What believers are saying
- FDA QMSR took effect February 2, 2026, forcing device teams into continuous compliance tooling.
- Vital Signals, an early customer, launched Signal Ring on July 20, 2026.
- Infera's blog updated September 26, 2026, signaling active product marketing and category creation.
What critics are saying
- $2.6 million March 17, 2025 seed funding leaves Infera exposed to enterprise sales delays.
- Greenlight Guru, MasterControl, and Veeva already own device QMS budgets and long deployments.
- If pilots stall before repeatable revenue, Infera's 2025 seed runway ends in 2027.
What makes Infera Health unique
- Infera's AI-native continuous compliance monitors every workspace change across Google Drive, Jira, and GitHub.
- It targets ISO 13485, IEC 62304, and ISO 14971, not generic document management.
- July 22, 2026 hiring Nikki Batista, ex-FDA reviewer and WHOOP VP, deepens regulatory credibility.
Help us improve and share your feedback! Did you find this helpful?